A carregar...
Publicação
Extracorporeal life support in cardiogenic shock: exploring before liberalizing
| Nome: | Descrição: | Tamanho: | Formato: | |
|---|---|---|---|---|
| 67.43 KB | Adobe PDF |
Autores
Orientador(es)
Resumo(s)
Cardiogenic shock (CS) is the leading cause of death after acute myocardial infarction (AMI), affecting up to
10% of the patients. Despite all the recent advances, CS is invariably associated with mortality rates around 40-50%. Interestingly, some reports even describe a recent increase in the probability of developing CS after AMI and in the mortality rates, probably due to ageing of population and increased risk profiles. When general intensive care measures are insufficient, mechanical circulatory support is an option, with extracorporeal membrane oxygenation (ECMO) being one of the most popular options nowadays. The development of
miniaturized systems and percutaneous cannulations have widened the use of ECMO. Although initial trials observed a significant increase of survival in CS with the use of ECMO, the evidence for its use in CS is scarce, and limited to observational studies and three small randomized trials.
Descrição
Copyright © 2023 Portuguese Journal of Cardiac Thoracic and Vascular Surgery Creative Commons License. This work is licensed under a Creative Commons Attribution 4.0 International License.
Palavras-chave
Contexto Educativo
Citação
Port J Card Thorac Vasc Surg. 2024 Feb 9;30(4):11-12
Editora
Sociedade Portuguesa de Cirurgia Cárdio-Torácica e Vascular